Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Clinical Efficacy of Tofacitinib Versus Methotrexate in Severe Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Randomized Controlled Trial

NCT07406204 is registered in ClinicalTrials.gov with Hayat Abad Medical Complex, Peshawar as lead sponsor.

NCT NCT07406204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07406204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Clinical Efficacy of Tofacitinib Versus Methotrexate in Severe Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Randomized Controlled Trial
Lead sponsor
Hayat Abad Medical Complex, Peshawar
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 15, 2026
Completion date
August 15, 2026
Enrollment
78 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata, alopecia totalis (at), alopecia universalis